i
This article was retracted on
The current study aimed to assess the effect of timosaponin AⅢ (T-AⅢ) on drug-metabolizing enzymes during anticancer therapy. The in vivo experiments were conducted on nude and ICR mice. Following a 24-day administration of T-AⅢ, the nude mice exhibited an induction of CYP2B10, MDR1, and CYP3A11 expression in the liver tissues. In the ICR mice, the expression levels of CYP2B10 and MDR1 increased after a three-day T-AⅢ administration. The in vitro assessments with HepG2 cells revealed that T-AⅢ induced the expression of CYP2B6, MDR1, and CYP3A4, along with constitutive androstane receptor (CAR) activation. Treatment with CAR siRNA reversed the T-AⅢ-induced increases in CYP2B6 and CYP3A4 expression. Furthermore, other CAR target genes also showed a significant increase in the expression. The up-regulation of murine CAR was observed in the liver tissues of both nude and ICR mice. Subsequent findings demonstrated that T-AⅢ activated CAR by inhibiting ERK1/2 phosphorylation, with this effect being partially reversed by the ERK activator t-BHQ. Inhibition of the ERK1/2 signaling pathway was also observed in vivo. Additionally, T-AⅢinhibited the phosphorylation of EGFR at Tyr1173 and Tyr845, and suppressed EGF-induced phosphorylation of EGFR, ERK, and CAR. In the nude mice, T-AⅢ also inhibited EGFR phosphorylation. These results collectively indicate that T-AⅢ is a novel CAR activator through inhibition of the EGFR pathway.
Fundings
This study was supported by the National Natural Science Foundation of China (Grant Nos. 82073934, 81872937, and 81673513).
Acknowledgments
None.
CHANGE HISTORY
A Correction to this paper has been published:
https://doi.org
The Retraction Note was updated to reflect reception of statements of disagreement from all authors.
This article has been retracted.Please see the Retraction Notice for more detail:
https://doi.org
| [1] |
Wang Y, Dan Y, Yang D, et al. The genus Anemarrhena Bunge: a review on ethnopharmacology, phytochemistry and pharmacology[J]. J Ethnopharmacol, 2014, 153(1): 42-60. doi: 10.1016/j.jep.2014.02.013
|
| [2] |
Zhang M, Qu J, Gao Z, et al. Timosaponin AIII induces G2/M arrest and apoptosis in breast cancer by activating the ATM/Chk2 and p38 MAPK signaling pathways[J]. Front Pharmacol, 2021, 11: 601468. doi: 10.3389/fphar.2020.601468
|
| [3] |
Lin Y, Zhao W, Shi W, et al. Pharmacological activity, pharmacokinetics, and toxicity of timosaponin AIII, a natural product isolated from Anemarrhena asphodeloides Bunge: a review[J]. Front Pharmacol, 2020, 11: 764. doi: 10.3389/fphar.2020.00764
|
| [4] |
Zhou Z, Zhao W, Xiao Y, et al. Antiangiogenesis effect of timosaponin AIII on HUVECs in vitro and zebrafish embryos in vivo[J]. Acta Pharmacol Sin, 2020, 41(2): 260-269. doi: 10.1038/s41401-019-0291-z
|
| [5] |
Zhou C, Yu T, Zhu R, et al. Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation[J]. Int J Biol Sci, 2023, 19(5): 1471-1489. doi: 10.7150/ijbs.77979
|
| [6] |
Stern S, Kurian R, Wang H. Clinical relevance of the constitutive androstane receptor[J]. Drug Metab Dispos, 2022, 50(7): 1010-1018. doi: 10.1124/dmd.121.000483
|
| [7] |
Honkakoski P. Searching for constitutive androstane receptor modulators[J]. Drug Metab Dispos, 2022, 50(7): 1002-1009. doi: 10.1124/dmd.121.000482
|
| [8] |
Sueyoshi T, Kawamoto T, Zelko I, et al. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene[J]. J Biol Chem, 1999, 274(10): 6043-6646. doi: 10.1074/jbc.274.10.6043
|
| [9] |
Goodwin B, Hodgson E, D'Costa DJ, et al. Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor[J]. Mol Pharmacol, 2002, 62(2): 359-365. doi: 10.1124/mol.62.2.359
|
| [10] |
Gerbal-Chaloin S, Daujat M, Pascussi JM, et al. Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor[J]. J Biol Chem, 2002, 277(1): 209-217. doi: 10.1074/jbc.M107228200
|
| [11] |
Wortham M, Czerwinski M, He L, et al. Expression of constitutive androstane receptor, hepatic nuclear factor 4α and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver[J]. Drug Metab Dispos, 2007, 35(9): 1700-1710. doi: 10.1124/dmd.107.016436
|
| [12] |
Yoshinari K, Yoda N, Toriyabe T, et al. Constitutive androstane receptor transcriptionally activates human CYP1A1 and CYP1A2 genes through a common regulatory element in the 5′-flanking region[J]. Biochem Pharmacol, 2010, 79(2): 261-269. doi: 10.1016/j.bcp.2009.08.008
|
| [13] |
Osabe M, Sugatani J, Fukuyama T, et al. Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet[J]. Drug Metab Dispos, 2008, 36(2): 294-303. doi: 10.1016/S0169-409X(02)00077-7
|
| [14] |
Maglich JM, Stoltz CM, Goodwin B, et al. Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification[J]. Mol Pharmacol, 2002, 62(3): 638-646. doi: 10.1124/mol.62.3.638
|
| [15] |
Yanagiba Y, Ito Y, Kamijima M, et al. Octachlorostyrene induces cytochrome P450, UDP-glucuronosyltransferase, and sulfotransferase via the aryl hydrocarbon receptor and constitutive androstane receptor[J]. Toxicol Sci, 2009, 111(1): 19-26. doi: 10.1093/toxsci/kfp130
|
| [16] |
Burk O, Arnold KA, Geick A, et al. A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression[J]. Biol Chem, 2005, 386(6): 503-513. doi: 10.1515/BC.2005.060
|
| [17] |
Banerjee M, Robbins D, Chen TS. Targeting xenobiotic receptors PXR and CAR in human diseases[J]. Drug Discov Today, 2015, 20(5): 618-628. doi: 10.1016/j.drudis.2014.11.011
|
| [18] |
Yang H, Wang H. Signaling control of the constitutive androstane receptor (CAR)[J]. Protein Cell, 2014, 5(2): 113-123. doi: 10.1007/s13238-013-0013-0
|
| [19] |
Koike C, Moore R, Negishi M. Extracellular signal-regulated kinase is an endogenous signal retaining the nuclear constitutive active/androstane receptor (CAR) in the cytoplasm of mouse primary hepatocytes[J]. Mol Pharmacol, 2007, 71(5): 1217-1221. doi: 10.1124/mol.107.034538
|
| [20] |
Shizu R, Osabe M, Perera L, et al. Phosphorylated nuclear receptor CAR forms a homodimer to repress its constitutive activity for ligand activation[J]. Mol Cell Biol, 2017, 37(10): e00649-16. doi: 10.1128/MCB.00649-16
|
| [21] |
Mutoh S, Sobhany M, Moore R, et al. Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling[J]. Sci Signal, 2013, 6(274): ra31. doi: 10.1126/scisignal.2003705
|
| [22] |
Zhao Y, Zhou J, Zhang M, et al. Cytotoxic steroidal saponins from the rhizome of Anemarrhena asphodeloides[J]. Steroids, 2020, 155: 108557. doi: 10.1016/j.steroids.2019.108557
|
| [23] |
Mutoh S, Osabe M, Inoue K, et al. Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3)[J]. J Biol Chem, 2009, 284(50): 34785-34792. doi: 10.1074/jbc.M109.048108
|
| [24] |
Osabe M, Negishi M. Active ERK1/2 protein interacts with the phosphorylated nuclear constitutive active/androstane receptor (CAR; NR1I3), repressing dephosphorylation and sequestering CAR in the cytoplasm[J]. J Biol Chem, 2011, 286(41): 35763-35769. doi: 10.1074/jbc.M111.284596
|
| [25] |
de Boussac H, Gondeau C, Briolotti P, et al. Epidermal growth factor represses constitutive androstane receptor expression in primary human hepatocytes and favors regulation by pregnane X receptor[J]. Drug Metab Dispos, 2018, 46(3): 223-236. doi: 10.1124/dmd.117.078683
|
| [26] |
Jin Q, Wu J, Wu Y, et al. Optical substrates for drug-metabolizing enzymes: recent advances and future perspectives[J]. Acta Pharm Sin B, 2022, 12(3): 1068-1099. doi: 10.1016/j.apsb.2022.01.009
|
| [27] |
Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation[J]. Pharmacol Ther, 2013, 138(1): 103-141. doi: 10.1016/j.pharmthera.2012.12.007
|
| [28] |
Hedrich WD, Hassan HE, Wang H. Insights into CYP2B6-mediated drug-drug interactions[J]. Acta Pharm Sin B, 2016, 6(5): 413-425. doi: 10.1016/j.apsb.2016.07.016
|
| [29] |
Robey RW, Pluchino KM, Hall MD, et al. Revisiting the role of ABC transporters in multidrug-resistant cancer[J]. Nat Rev Cancer, 2018, 18(7): 452-464. doi: 10.1038/s41568-018-0005-8
|
| [30] |
Chen J, Jia X, Wang H, et al. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway[J]. Int J Oncol, 2016, 48(5): 2063-2070. doi: 10.3892/ijo.2016.3423
|
| [31] |
Dai J, He Y, Fang J, et al. In vitro evaluation of the interaction of seven biologically active components in Anemarrhenae rhizoma with P-gp[J]. Molecules, 2022, 27(23): 8556. doi: 10.3390/molecules27238556
|
| [32] |
Negishi M, Kobayashi K, Sakuma T, et al. Nuclear receptor phosphorylation in xenobiotic signal transduction[J]. J Biol Chem, 2020, 295(45): 15210-15225. doi: 10.1074/jbc.REV120.007933
|
| [33] |
Tzameli I, Pissios P, Schuetz EG, et al. The xenobiotic compound 1, 4-bis[2-(3, 5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR[J]. Mol Cell Biol, 2000, 20(9): 2951-2958. doi: 10.1128/MCB.20.9.2951-2958.2000
|
| [34] |
Gschwind A, Fischer OM, Ullrich A. The discovery of receptor tyrosine kinases: targets for cancer therapy[J]. Nat Rev Cancer, 2004, 4(5): 361-370. doi: 10.1038/nrc1360
|
| [35] |
Sabbah DA, Hajjo R, Sweidan K. Review on epidermal growth factor receptor (EGFR) structure, signaling pathways, interactions, and recent updates of EGFR inhibitors[J]. Curr Top Med Chem, 2020, 20(10): 815-834. doi: 10.2174/1568026620666200303123102
|
| [36] |
Negishi M. Phenobarbital meets phosphorylation of nuclear receptors[J]. Drug Metab Dispos, 2017, 45(5): 532-539. doi: 10.1124/dmd.116.074872
|
| [37] |
Carazo A, Dusek J, Holas O, et al. Teriflunomide is an indirect human constitutive androstane receptor (CAR) activator interacting with epidermal growth factor (EGF) signaling[J]. Front Pharmacol, 2018, 9: 993. doi: 10.3389/fphar.2018.00993
|
| [38] |
Zhang J, Huang W, Chua SS, et al. Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR[J]. Science, 2002, 298(5592): 422-424. doi: 10.1126/science.1073502
|
| [39] |
Huang W, Zhang J, Washington M, et al. Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor[J]. Mol Endocrinol, 2005, 19(6): 1646-1653. doi: 10.1210/me.2004-0520
|
| [40] |
Yamamoto Y, Moore R, Goldsworthy TL, et al. The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice[J]. Cancer Res, 2004, 64(20): 7197-7200. doi: 10.1158/0008-5472.CAN-04-1459
|